Clinical Trials Logo
  1. Home
  2. Pericarditis
  3. NCT00946907

Benign Acute Pericarditis: Brief Versus Longer Treatment Using Aspirin — pericardite  

Pericarditis Clinical Trial

Official title:
Benign Acute Pericarditis: Brief Versus Longer Treatment. Randomized, Multicentric, Double Blind, Non Inferiority Trial

Clinical Trial Summary

Treatment of pericarditis largely remains empirical due to the relative lack of randomized controlled trials. Nevertheless, some recommendations have been formulated to guide management and follow-up of acute pericarditis. Aspirin or an NSAID at medium to high dosages is the mainstay of treatment. Optimal length of treatment is not established.

PERICARDITE is a French multicentric placebo controlled double blind randomized trial assessing efficacy of a brief treatment based on Aspirin (4 days) versus a longer treatment (21days) in treating a first episode of probably idiopathic acute pericarditis. It is a non inferiority trial.

Exclusion criteria are: diseases known to cause pericarditis: (recent myocardial infarction, autoimmune disease, postpericardiotomy syndromes, connective tissue disease, tuberculosis, neoplastic disease).

Primary endpoint is: 30 days recovery defined as the normalization of all clinical and paraclinical initial abnormalities.

Secondary endpoint is: 6-month recurrence.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00946907
Study type Interventional
Source University Hospital, Brest
Contact
Status Terminated
Phase Phase 4
Start date July 2009
Completion date July 2011
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03253315 - Management of Pericarditis in Children. N/A
Recruiting NCT02754713 - Prognostic Biomarkers in Patients With Acute Pericarditis N/A
Completed NCT00235079 - Study of Colchicine to Treat and Prevent Recurrent Pericarditis After Failure of Conventional Treatment. Phase 4
Completed NCT04906720 - Post-Ablation Pericarditis Reduction Study Phase 2
Not yet recruiting NCT05805930 - Therapeutic Approach in Colchicine-resistant Recurrent pEricarditis in Children Phase 3
Not yet recruiting NCT06411340 - Inflammation in Acute Cardiovascular Diseases - the CArdiovascular Inflammation Registry (CAIR)
Not yet recruiting NCT05925790 - Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR Levels
Recruiting NCT04294771 - JOint Use of Database to Identify Risk Factors of CARDio-vascular Toxicity Induced by Immune Checkpoint Inhibitors
Enrolling by invitation NCT04774549 - Inflammatory Cardiomyopathy Bern Registry
Completed NCT02083510 - Apolipoprotein CIII Reduction Via Colchicine Phase 0
Enrolling by invitation NCT01063582 - Noise, a Risk for Heart in Airplane Pilots N/A
Completed NCT04692766 - Study to Evaluate the Efficacy and Safety of RPH-104 Treatment in Patients With Idiopathic Recurrent Pericarditis Phase 2/Phase 3
Active, not recruiting NCT03231449 - A Survey of Hospitalizations in Cardiology Units in Sub-Saharan Africa
Completed NCT00128453 - Study of Colchicine to Treat Acute Pericarditis and Prevent Recurrences Phase 3
Completed NCT00128414 - Study of Colchicine to Treat and Prevent Recurrent Pericarditis (First Episode) Phase 3
Recruiting NCT05046002 - COVID-19 Vaccine-induced Inflammatory Heart Disease Prevalence Registry
Recruiting NCT06103123 - MYocarditis and/or Pericarditis Following mRNA COVID-19 VACCination National Surveillance Study
Completed NCT01395082 - ACAM2000® Myopericarditis Registry